Table 2. Primary and Secondary Outcomes.
Outcome | Dexamethasone (N=2104) |
Usual Care (N=4321) |
Rate or Risk Ratio (95% CI)* |
---|---|---|---|
no./total no. of patients (%) | |||
Primary outcome | |||
Mortality at 28 days | 482/2104 (22.9) | 1110/4321 (25.7) | 0.83 (0.75–0.93) |
Secondary outcomes | |||
Discharged from hospital within 28 days | 1413/2104 (67.2) | 2745/4321 (63.5) | 1.10 (1.03–1.17) |
Invasive mechanical ventilation or death† | 456/1780 (25.6) | 994/3638 (27.3) | 0.92 (0.84–1.01) |
Invasive mechanical ventilation | 102/1780 (5.7) | 285/3638 (7.8) | 0.77 (0.62–0.95) |
Death | 387/1780 (21.7) | 827/3638 (22.7) | 0.93 (0.84–1.03) |
Rate ratios have been adjusted for age with respect to the outcomes of 28-day mortality and hospital discharge. Risk ratios have been adjusted for age with respect to the outcome of receipt of invasive mechanical ventilation or death and its subcomponents.
Excluded from this category are patients who were receiving invasive mechanical ventilation at randomization.